BR112012005629A2 - sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma - Google Patents

sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma

Info

Publication number
BR112012005629A2
BR112012005629A2 BR112012005629A BR112012005629A BR112012005629A2 BR 112012005629 A2 BR112012005629 A2 BR 112012005629A2 BR 112012005629 A BR112012005629 A BR 112012005629A BR 112012005629 A BR112012005629 A BR 112012005629A BR 112012005629 A2 BR112012005629 A2 BR 112012005629A2
Authority
BR
Brazil
Prior art keywords
analogue
therapeutic system
transdermal therapeutic
administering fentanyl
fentanyl
Prior art date
Application number
BR112012005629A
Other languages
English (en)
Inventor
Björn Schurad
Ingo Teutsch
Nouha Salman
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41559211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012005629(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Ag filed Critical Acino Ag
Publication of BR112012005629A2 publication Critical patent/BR112012005629A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112012005629A 2009-09-14 2010-09-14 sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma BR112012005629A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09170223A EP2295046B1 (de) 2009-09-14 2009-09-14 Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
PCT/EP2010/063433 WO2011029948A2 (de) 2009-09-14 2010-09-14 Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon

Publications (1)

Publication Number Publication Date
BR112012005629A2 true BR112012005629A2 (pt) 2016-08-02

Family

ID=41559211

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012005629A BR112012005629A2 (pt) 2009-09-14 2010-09-14 sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma

Country Status (10)

Country Link
US (1) US20120209223A1 (pt)
EP (2) EP2295046B1 (pt)
JP (1) JP2013504546A (pt)
CN (1) CN102548546A (pt)
AU (1) AU2010294160A1 (pt)
BR (1) BR112012005629A2 (pt)
CA (1) CA2773008A1 (pt)
IN (1) IN2012DN01225A (pt)
MX (1) MX2012002727A (pt)
WO (1) WO2011029948A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5558074B2 (ja) * 2009-10-15 2014-07-23 日東電工株式会社 塗膜保護シート
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
EP2599478A1 (de) * 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US9072682B2 (en) * 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
CN104825426A (zh) * 2015-05-26 2015-08-12 韩晓明 双相褪黑素贴剂
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
WO2018194879A1 (en) * 2017-04-19 2018-10-25 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
US10377114B2 (en) * 2017-04-20 2019-08-13 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CN111419827B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种阿芬太尼透皮给药的药物组合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US20010033858A1 (en) * 2000-02-29 2001-10-25 Jie Zhang Transdermal drug patch
US20030026829A1 (en) 2001-03-16 2003-02-06 Venkatraman Subramanian S. Transdermal administration of fentanyl and analogs thereof
WO2004024155A1 (ja) 2002-09-13 2004-03-25 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
CN1640387A (zh) * 2004-01-15 2005-07-20 财团法人工业技术研究院 经皮吸收贴片及其制造方法
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
DE602004017164D1 (de) 2004-08-09 2008-11-27 Deutsches Krebsforsch Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP2042174B1 (en) * 2006-07-14 2017-12-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation

Also Published As

Publication number Publication date
EP2295046B1 (de) 2012-12-19
CA2773008A1 (en) 2011-03-17
CN102548546A (zh) 2012-07-04
WO2011029948A2 (de) 2011-03-17
WO2011029948A3 (de) 2011-10-13
MX2012002727A (es) 2012-05-08
EP2477616A2 (de) 2012-07-25
EP2295046A1 (de) 2011-03-16
US20120209223A1 (en) 2012-08-16
EP2477616B1 (de) 2013-08-14
JP2013504546A (ja) 2013-02-07
AU2010294160A1 (en) 2012-04-05
IN2012DN01225A (pt) 2015-04-10

Similar Documents

Publication Publication Date Title
BR112012005629A2 (pt) sistema terapêutico transdérmico para administrar fentanila ou um análogo da mesma
BRPI0910740A2 (pt) sistema terapêutico transdérmico para a administração de fentanila ou um análogo da mesma
DK2274032T3 (da) Anordning til medicinindgivelse
BRPI0913214A2 (pt) sistema de fornecimento de drogas transdérmico estabilizado
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
PL2515886T3 (pl) Przezskórny układ terapeutyczny do podawania rywastygminy lub jej pochodnych
BR112013014616A2 (pt) sistema terapêutico transdérmico para a administração de uma substância ativa
CO6920282A2 (es) Dispositivo para inyección automática de dosis de fármaco
DK2445570T3 (da) Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
CU24166B1 (es) Dispositivo para inyección automática de dosis de fármaco
DK2403569T3 (da) Lægemiddelafgivelsesanordning med tilbagetrækkelig nål
DK2506820T3 (da) Integreret hændelsesmarkersystem med farmaceutisk produkt til indtagelse
DK2641614T3 (da) Farmaceutisk præparat integreret med mikronåle til hudbehandling
BRPI0909653A2 (pt) sistema terapêutico transdérmico com membrama estabilizada
BRPI1006948A2 (pt) sistema de identificação de medicamento para dispositivos de injeção de doses múltiplas
BRPI1005433A2 (pt) preparações farmacêuticas transdérmicas
BRPI1015124A2 (pt) compostos aromáticos substituídos e usos farmacêuticos dos mesmos
BR112012031836A2 (pt) combinação farmacêutica para o tratamento da dor
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
BRPI0908231A2 (pt) Sistema de liberação de fármaco com efeito estabilizante
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
DK2353632T3 (da) Medicinsk anordning til lokal lægemiddelafgivelse
BRPI0919526A2 (pt) derivado de ciclo-hexano, produto farmacêutico, analgésico, e, droga terapêutica para dor neuropática e/ou dor nociceptiva

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.